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SYRINGOHYDROMYELIA ASSOCIATED TO
THERAPEUTIC PROCEDURES FOR SEVERE
FORMS OF NEUROCYSTICERCOSIS 
Case report
Donizeti Honorato1, Wilson Borges2, Antonio Augusto Roth Vargas1, Ricardo Ramina1
ABSTRACT - Syringohydromyelia is defined as a longitudinal dilatation of the central canal of the spinal
cord with accumulated cerebrospinal fluid. This condition may cause neurologic deficits when the cavity
enlarges and compresses the spinal cord. We present the case of a 33 years-old female with progressive
paraparesis caused by syringohydromyelia. This patient underwent previously multiple clinical and surgi-
cal treatments for severe form of neurocysticercosis. Surgical decompression of the posterior fossa and syringos-
tomy resolved the neurologic symptoms. The possibility of syringohydromyelia should be considered in the
case of patients who have previously undergone surgical and clinical treatment for severe form of neuro-
cysticercosis.
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Hidrossiringomielia associada ao tratamento de formas severas de neurocisticercose: relato de caso
RESUMO - A hidrossiringomielia é definida como uma dilatação longitudinal do canal central da medula
espinhal cujo conteúdo é semelhante ao líquido cefalorraquidiano e que freqüentemente produz compro-
metimento neurológico. Apresentamos o caso de uma paciente de 33 anos, submetida a vários tratamen-
tos clínicos e cirúrgicos para neurocisticercose severa, que tardiamente apresentou quadro de paraparesia
progressiva, quando foi então, detectada uma hidrosiringomielia. O tratamento cirúrgico obteve resolução
do quadro neurológico e considerável diminuição da cavidade hidrosiringomiélica. A possibilidade do desen-
volvimento de hidrossiringomielia nas formas severas de neurocisticercose submetidas a vários tipos de trata-
mento deve ser suspeitada e investigada.
PALAVRAS-CHAVE: hidrossiringomielia, neurocisticercose, tratamento cirúrgico.
Over the last decades, neurocysticercosis (NC)
has become the most common parasite affecting
of the central nervous system and it is an endem-
ic disease in Asia, Africa and Latin America1,2. This
parasite occurs in the human due to a deviation
in the life cycle of the Taenia solium in the pig, its
usual intermediary host. There are two well defined
larval forms: Cysticercus cellulosae (cysts with a dia-
meter of 1 to 20 mm containing a scolex) and Cys-
ticercus racemosus (cysts of variable aspects with
a diameter of 40 to 120). The first type occurs wi-
thin the nervous parenchyma and the second in the
subarachnoid cisterns and ventricles. There is a third
form (intermediary) presenting multiple membra-
nous formations with a scolex. The clinical and
laboratory condition of NC is quite polymorphic.
Diagnosis is based on clinical observations, cerebros-
pinal fluid (CSF) examinations and neuroimaging
findings, mainly the computerized tomography (CT)
and magnetic resonance (MRI)2. 
Syringohydromyelia is the dilation of the cen-
tral canal of the spinal cord due to accumulation
of a fluid similar to CSF. These cavities differ from
the syringomyelia because they are lined with the
ependyma and are almost always associated with
the hydrocephaly3. However, the term syringo-
myelia includes the various kinds of posttraumat-
ic cysts that contain CSF, cysts associated with most
of the tumors of the spinal medulla and even post-
infected medullar cysts4. Communication of the
cavity with the IV ventricle is not common in syrin-
gomyelia occurring in only in only 10% of the cas-
es, but in syringohydromyelia it is very common.
Overall, all longitudinal medullar cavities are includ-
ed in the term syringomyelia. Generally two types
are identified: syringobulbia and syringomyelia. Sy-
ringobulbia occurs in the brain stem (medulla oblon-
gata and cervical spinal cord) and has several caus-
es: bone anomalies at the cranio-vertebral junction;
arachnoidal adherences and posterior fossa anom-
alies as the Arnold-Chiari syndrome.  Syringomyelia
is a longitudinal cavity of the spinal cord due to
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posttraumatic, post-surgical and post-infectious
arachanoid adherences, spinal cord medullar tu-
mors and other pathologies associated with spinal
dysraphism4-6. Syringomyelia is associated with
blockage of the CSF circulation at the site or at a
distance of the cavity. This fact implies that obstruc-
tion of the subarachanoid space impedes the spon-
taneous equilibration of the CSF pressure. It may
occur even under physiological circumstances as pul-
sation of the blood vessels in the choroid plexus,
repetitive physical efforts and coughing episodes.
These situations increase the perimedullar CSF
Fig 1. T2-weigted MRI ((A) sagital view, and (B) axial view) reveals a large cervical syringohydromyelic cavity.
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DISCUSSION
The clinical manifestations of NC are unspecif-
ic and varied. This polymorphism is due to individ-
ual differences in number, size and location of the
lesions as well as the immunologic response of
the host. Epilepsy is the most common presenta-
tion of NC (50-80%) and is usually the first or only
clinical symptom of disease. Headaches as an iso-
lated symptom occur in about 20% of the cases and
intracranial hypertension in 15%. Meningitis is
present in 8% and other clinical combinations are
present in 2%7,8.
Neurocysticercosis presenting cysts or calcifica-
tion within the cerebral parenchyma are termed
Cysticercus cellulosae and has the best prognosis
with clinical treatment.  Cysticercus racemose tends
to be more severe and the parasite is generally lod-
ged in the arachnoid cisterns or inside the ventri-
cles. Occurrence of vasculits and hydrocephalus is
frequent in this form of NC and clinical treatment
is not always effective. Our patient presented this
clinical condition. 
Several researchers state that the presence of
hydrocephaly qualify the condition as a severe form
of NC. According to Torrealba et al.9 and Agapejev
et al.2 the prognosis is worse when hydrocephalus
is the first manifestation. Insertion of a VPS should
be performed before cystical treatment, which
should begin as soon as possible2,8.In our case the
low pressure VPS, probably reduced the CSF flow
in the cerebral aqueduct resulting in an isolated
IV ventricle. The repeated clinical treatment, the
direct approach to the IV ventricle and the ventri-
culitis affected the CSF circulation at the cranio-ver-
tebral joint. Obstruction of the inferior orifice of
the aqueduct and the ventricles exits, observed in
the MRI, probably caused the CSF pulse wave  at
each systole. These waves directed towards the
central canal through the obex, caused dilation and
formation of the syringohydromyelic cavity, corrob-
orating Gardner’s theory10. The diagnosis of syringo-
hydromyelia should be considered when patients
treated for severe forms of NC present pyramidal
signs and paraparesis. An isolated IV ventricle is usu-
ally easily identifiable in the CT and MRI11, but the
cervical segments of the spinal cord are not stud-
ied in these cases, impeding the diagnosis of syrin-
gohydromyelia. Several surgical techniques were
described for treatment of syringomyelia6. The
procedure used to reestablish CSF circulation in the
posterior fossa of our patient was widening the
craniectomy by resection of the posterior arch of the
pressure provoking CSF flow into the spinal cord
through Virchow-Robin space. 
A patient presenting syringohydromyelia after
multiple treatments for severe form of neurocys-
ticercose is reported. A similar case could not be
found in the literature.
CASE
A 33-year old white female started in June 1998 to
present symptoms of increased intracranial pressure (ICP).
Hydrocephalus was diagnosed and ventricle-peritoneal
shunts (VPS) was inserted at another department. In
September 1998 a cysticercotic cyst was removed from
the left temporal region and treatment with albenda-
zole was carried out. On January 7, 1999 she was admit-
ted to our clinic with symptoms of cysticercotic menin-
gitis. The diagnosis was confirmed by CSF examination.
Her clinical condition and CSF improved (ELISA test for
cysticercosis was negative) after new treatment with
albendazole. This therapy was repeated in February 1999
and February 2000. In March 2000, the patient com-
plained frequent dizziness, nausea and occasional vo-
miting. A MRI-examination showed diffuse arachnoidi-
tis and a cyst in the IV ventricle. On March 13, 2000, she
underwent a craniectomy of the posterior fossa to remo-
ve the IV ventricle cyst and  open the diffuse arachnoidi-
tis. The clinical condition improved after operation and
the patient became asymptomatic. One month after
surgery she developed an infection of the distal cateter
of the VPS with an abscess of the abdominal wall and
meningitis. The infection (caused by oxacillin -sensitive
Staphylococcus aureus) was adequately treated with
antibiotics. The entire VPS was removed and an exter-
nal ventricular drainage was inserted. A low pressure
shunt was implanted three weeks later. The patient sho-
wed a significant improvement. A control MRI was per-
formed in July 2001, and revealed dilatation of the IV
ventricle  due to obstruction of the inferior aqueduct
orifice and the lateral (Luschka) and median foramens
(Magendie) of the IV ventricle. The magnum foramen
was obliterated by the cerebellar tonsils and obex. Cer-
vical syringohydromyelia and suffusion in the medullar
parenchyma were also observed. The patient remained
asymptomatic, and no surgical treatment was proposed.
In December 2001, she developed progressive spas-
tic paraparesis and a MRI revealed increase of the hy-
drosyringomyelia (Fig 1). On December 3, 2001 a new
posterior fossa exposure, widening the previous craniec-
tomy and communicating the hydrosyringomyelia with
the subarachnoid space, was performed. Postoperatively
the patient presented remission of paraparesis. She pre-
sented no deficit at the last neurological control examina-
tion (July 2003). The postoperative MRI demonstrated
the reestablishment of normal CSF dynamics in the pos-
terior fossa with reduction of the cervical syringohydro-
myelic cavity (Fig 2). 
atlas, opening the arachnoid adherences that blo-
cked the IV ventricle, and create a communication
between the syringomyelic cavity and the magnum
cistern and the cervical perimedullar space. This pro-
cedure reestablished CSF circulation in the poste-
rior fossa as demonstrated by the MRI (Fig 2).
In conclusion, in severe forms of NC with hydro-
cephaly, a VPS should be the first procedure. Clinical
treatment with cysticidal drugs should be started
as soon as possible. Surgery of the posterior fossa
associated with clinical treatment in this form may
cause severe inflammatory reaction with ventriculi-
tis. Radiological investigation of the cervical region
is required because syringohydromyelia may be
diagnosed before these patients develop clinical
symptoms. The possible development of syringo-
hydromyelia should be considered in all patients
with severe forms of neurocysticercosis. 
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